References
- AgustíAEdwardsLDRennardSIEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsPersistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotypePLoS One20127e3748322624038
- GanWQManSFSenthilselvanASinDDAssociation between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisThorax20045957458015223864
- MagnussenHWatzHSystemic inflammation in chronic obstructive pulmonary disease and asthma: relation with comorbiditiesProc Am Thorac Soc2009664865120008868
- FanerRTal-SingerRRileyJHECLIPSE Study InvestigatorsLessons from ECLIPSE: a review of COPD biomarkersThorax20146966667224310110
- FerrariRTanniSECaramLMCorreaCCorreaCRGodoyIThree-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary diseaseRespir Res2013142423425215
- BroekhuizenRWoutersEFCreutzbergECScholsAMRaised CRP levels mark metabolic and functional impairment in advanced COPDThorax200661172216055618
- MoyMLTeylanMWestonNAGagnonDRDanilackVAGarshickEDaily step count is associated with plasma C-reactive protein and IL-6 in a US cohort with COPDChest201414554255024091482
- HurstJRDonaldsonGCPereraWRUse of plasma biomarkers at exacerbation of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200617486787416799074
- From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD)2010 Available from: http://www.goldcopd.com/
- MaltaisFDecramerMCasaburiRATS/ERS Ad Hoc Committee on Limb Muscle Dysfunction in COPDAn official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2014189e15e6224787074
- O’DonnellDELavenezianaPDyspnea and activity limitation in COPD: mechanical factorsCOPD2007422523617729066
- WatzHWaschkiBBoehmeCClaussenMMeyerTMagnussenHExtrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional studyAm J Respir Crit Care Med200817774375118048807
- GagnonPMaltaisFBouyerLDistal leg muscle function in patients with COPDCOPD20131023524223547635
- SteinbergJGBaABregeonFDelliauxSJammesYCytokine and oxidative responses to maximal cycling exercise in sedentary subjectsMed Sci Sports Exerc20073996496817545886
- ReihmaneDJurkaATretjakovsPDelaFIncrease in IL-6, TNF-alpha, and MMP-9, but not sICAM-1, concentrations depends on exercise durationEur J Appl Physiol201311385185822990627
- JammesYSteinbergJGBaADelliauxSBregeonFEnhanced exercise-induced plasma cytokine response and oxidative stress in COPD patients depend on blood oxygenationClin Physiol Funct Imaging20082818218818312445
- CockayneDAChengDTWaschkiBSystemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severityPLoS One20127e3862922701684
- SchindhelmRKvan der ZwanLPTeerlinkTSchefferPGMyeloperoxidase: a useful biomarker for cardiovascular disease risk stratification?Clin Chem2009551462147019556446
- RöpckeSHolzOLauerGRepeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputumPLoS One20127e4620723056262
- O’DonnellDELamMWebbKAMeasurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1998158155715659817708
- GiegerCGeistlingerLAltmaierEGenetics meets metabolomics: a genome-wide association study of metabolite profiles in human serumPLoS Genet20084e100028219043545
- RamsaySLStoegglWMWeinbergerKMGraberAGuggenbichlerWinventorsBiocrates Life Sciences AG, assigneeApparatus and method for analyzing a metabolite profileUnited States patent US20070004044200714
- FleissJLDesign and Analysis of Clinical ExperimentsNew YorkWiley1986
- FebbraioMAPedersenBKMuscle-derived interleukin-6: mechanisms for activation and possible biological rolesFASEB J2002161335134712205025
- AnatoliotakisNDeftereosSBourasGMyeloperoxidase: expressing inflammation and oxidative stress in cardiovascular diseaseCurr Top Med Chem20131311513823470074
- NichollsSJHazenSLMyeloperoxidase and cardiovascular diseaseArterioscler Thromb Vasc Biol2005251102111115790935
- EiserichJPBaldusSBrennanMLMyeloperoxidase, a leukocytederived vascular NO oxidaseScience20022962391239412089442
- ReihmaneDJurkaATretjakovsPThe relationship between maximal exercise-induced increases in serum IL-6, MPO and MMP-9 concentrationsScand J Immunol20127618819222594650
- ReihmaneDTretjakovsPKaupeJSarsMValanteRJurkaASystemic pro-inflammatory molecule response to acute submaximal exercise in moderately and highly trained athletesEnviron Exp Biol201210107112
- AutenriethCSEmenyRTHerderCMyeloperoxidase, but not oxidized LDL, is associated with leisure-time physical activity: results from the MONICA/KORA Augsburg Studies 1984–1995Atherosclerosis201121977477721880315
- WalshNPGleesonMShephardRJPosition statement. Part one: immune function and exerciseExerc Immunol Rev20111766321446352
- KlebanoffSJMyeloperoxidase: friend and foeJ Leukoc Biol20057759862515689384
- OudijkEJNijhuisEHZwankMDSystemic inflammation in COPD visualised by gene profiling in peripheral blood neutrophilsThorax20056053854415994259
- JobinJMaltaisFDoyonJFChronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscleJ Cardiopulm Rehabil1998184324379857275
- DavidsonWJVerityWSTravesSLLeighRFordGTEvesNDEffect of incremental exercise on airway and systemic inflammation in patients with COPDJ Appl Physiol1985201211220492056
- RabinovichRAFiguerasMArditeEIncreased tumour necrosis factor-alpha plasma levels during moderate-intensity exercise in COPD patientsEur Respir J20032178979412765422